Literature DB >> 30203709

Stilbenoid pterostilbene complexed with cyclodextrin preserves left ventricular function after myocardial infarction in rats: possible involvement of thiol proteins and modulation of phosphorylated GSK-3β.

Denise Lacerda1, Vanessa Ortiz2, Patrick Türck2, Cristina Campos-Carraro2, Alexsandra Zimmer2, Rayane Teixeira2, Sara Bianchi3, Alexandre Luz de Castro2,4, Paulo Cavalheiro Schenkel2, Adriane Belló-Klein2, Valquiria Linck Bassani3, Alex Sander da Rosa Araujo1,2.   

Abstract

Oxidative stress alters signalling pathways for survival and cell death favouring the adverse remodelling of postmyocardial remnant cardiomyocytes, promoting functional impairment. The administration of pterostilbene (PTS), a phytophenol with antioxidant potential, can promote cardioprotection and represents a therapeutic alternative in acute myocardial infarction (AMI). The present study aims to explore the effects of oral administration of PTS complexed with hydroxypropyl-β-cyclodextrin HPβCD (PTS:HPβCD complex) on the glutathione cycle, thiol protein activities and signalling pathways involving the protein kinase B (AKT) and glycogen synthase kinase-3β (GSK-3β) proteins in the left ventricle (LV) of infarcted rats. Animals were submitted to acute myocardial infarction through surgical ligation of the descending anterior branch of the left coronary artery and received over 8 days, by gavage, PTS:HPβCD complex at dose of 100 mg kg-1 day-1 (AMI + PTS group) or vehicle (aqueous solution with HPβCD) divided into Sham-operated (SHAM) and infarcted (AMI) groups. The results showed that the PBS: HPβCD complex decreased lipid peroxidation, prevented the decrease in thioredoxin reductase (TRxR) activity, and increased the activity of glutathione-S-transferase (GST) and glutaredoxin (GRx). Additionally, the expression of nuclear factor-erythroid two (Nrf2) and p-GSK-3β was increased, whereas the p-GSK-3β/GSK-3β ratio was reduced in the LV of the infarcted animals. Overall, the PTS:HPβCD complex modulates activity of thiol-dependent enzymes and induces to the expression of antioxidant proteins, improving systolic function and mitigating the adverse cardiac remodelling post infarction.

Entities:  

Keywords:  Antioxidant; cardioprotection; cyclodextrin; heart failure; natural products; stilbene

Mesh:

Substances:

Year:  2018        PMID: 30203709     DOI: 10.1080/10715762.2018.1506115

Source DB:  PubMed          Journal:  Free Radic Res        ISSN: 1029-2470


  7 in total

Review 1.  Molecular mechanisms of doxorubicin-induced cardiotoxicity: novel roles of sirtuin 1-mediated signaling pathways.

Authors:  Jie Wang A; Jingjing Zhang; Mengjie Xiao; Shudong Wang; Jie Wang B; Yuanfang Guo; Yufeng Tang; Junlian Gu
Journal:  Cell Mol Life Sci       Date:  2021-01-13       Impact factor: 9.261

2.  Pterostilbene complexed with cyclodextrin exerts antimicrobial and anti-inflammatory effects.

Authors:  Yi Rong Ivan Lim; Philip M Preshaw; Lum Peng Lim; Marianne Meng Ann Ong; Hai-Shu Lin; Kai Soo Tan
Journal:  Sci Rep       Date:  2020-06-03       Impact factor: 4.379

3.  PGC1α activation by pterostilbene ameliorates acute doxorubicin cardiotoxicity by reducing oxidative stress via enhancing AMPK and SIRT1 cascades.

Authors:  Dong Liu; Zhiqiang Ma; Liqun Xu; Xiaoyan Zhang; Shubin Qiao; Jiansong Yuan
Journal:  Aging (Albany NY)       Date:  2019-11-16       Impact factor: 5.682

Review 4.  New Insights Into the Role of Mitochondria Quality Control in Ischemic Heart Disease.

Authors:  Yanguo Xin; Xiaodong Zhang; Jingye Li; Hui Gao; Jiayu Li; Junli Li; Wenyu Hu; Hongwei Li
Journal:  Front Cardiovasc Med       Date:  2021-11-26

5.  Pterostilbene Reduces Experimental Myocardial Infarction-Induced Oxidative Stress in Lung and Right Ventricle.

Authors:  Silvio Tasca; Cristina Campos; Denise Lacerda; Vanessa D Ortiz; Patrick Turck; Sara E Bianchi; Alexandre L de Castro; Adriane Belló-Klein; Valquiria Bassani; Alex Sander da Rosa Araújo
Journal:  Arq Bras Cardiol       Date:  2022-02       Impact factor: 2.000

Review 6.  NRF2 in Cardiovascular Diseases: a Ray of Hope!

Authors:  Ruju Vashi; Bhoomika M Patel
Journal:  J Cardiovasc Transl Res       Date:  2020-11-25       Impact factor: 4.132

Review 7.  Role of Nrf2 and Its Activators in Cardiocerebral Vascular Disease.

Authors:  Liangkai Cheng; Hong Zhang; Fang Wu; Zhongqiu Liu; Yuanyuan Cheng; Caiyan Wang
Journal:  Oxid Med Cell Longev       Date:  2020-08-05       Impact factor: 6.543

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.